American Society of Clinical Oncology technology assessment: Chemotherapy sensitivity and resistance assays

Journal of Clinical Oncology

Volumn 22, Issue 17, 2004, Pages 3631-3638

  Schrag, Deborah ^a   Garewal, Harinder S ^a   Burstein, Harold J ^a   Samson, David J ^a   Von Hoff, Daniel D ^a   Somerfield, Mark R ^a  

^a AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CLINICAL PRACTICE; HUMAN; MEDICAL LITERATURE; MEDICAL SOCIETY; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; ARTICLE; CLINICAL TRIAL; DRUG SCREENING; EVALUATION; LITERATURE; METHODOLOGY; ONCOLOGY; PRACTICE GUIDELINE;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; DRUG SCREENING ASSAYS, ANTITUMOR; MEDICAL ONCOLOGY; PRACTICE GUIDELINES; REVIEW LITERATURE; SOCIETIES, MEDICAL;

EID: 4444267702     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.05.065     Document Type: Review

References (17)

1. Samson DJ, Seidenfeld J, Ziegler K, et al: Chemotherapy sensitivity and resistance assays: A systematic review. J Clin Oncol 22:10.1200/JCO.2004.04.077
2. Cortazar P, Gazdar AF, Woods E, et al: Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing. Clin Cancer Res 3:741-747, 1997
3. Gazdar AF, Steinberg SM, Russell EK, et al: Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial. J Natl Cancer Inst 82:117-124, 1990
4. Shaw GL, Gazdar AF, Phelps R, et al: Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 53:5181-5187, 1993
5. Shaw GL, Gazdar AF, Phelps R, et al: Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem Suppl 24:173-185, 1996
6. Von Hoff DD, Clark GM, Stogdill BJ, et al: Prospective clinical trial of a human tumor cloning system. Cancer Res 43:1926-1931, 1983
7. Von Hoff DD, Sandbach JF, Clark GM, et al: Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Inst 82:110-116, 1990
8. Von Hoff DD, Kronmal R, Salmon SE, et al: A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer 67:20-27, 1991
9. Wilbur DW, Camacho ES, Hilliard DA, et al: Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill. Br J Cancer 65:27-32, 1992
10. Xu JM, Song ST, Tang ZM, et al: Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. Breast Cancer Res Treat 53:77-85, 1999
11. Kurbacher CM, Cree IA, Bruckner HW, et al: Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer. Anticancer Drugs 9:51-57, 1998
12. Maenpaa JU, Heinonen E, Hinkka SM, et al: The subrenal capsule assay in selecting chemotherapy for ovarian cancer: A prospective randomized trial. Gynecol Oncol 57:294-298, 1995
13. Loizzi V, Chan JK, Osann K, et al: Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol 189:1301-1307, 2003
14. Kern DH, Drogemuller CR, Kennedy MC, et al: Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res 45:5436-5441, 1985
15. Kern DH, Weisenthal LM: Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. J Natl Cancer Inst 82:582-588, 1990
16. Cortazar P, Johnson BE: Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol 17:1625-1631, 1999
17. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98, 2002